
Illumina's Bid to Beat Cancer with DNA Tests
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
LIMITED TIME OFFER
3 months free
Offer ends July 31, 2025 at 11:59PM PT.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 3 months. Cancel anytime.
Buy for $1.95
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use, License, and Amazon's Privacy Notice. Taxes where applicable.
-
Narrated by:
-
Todd Mundt
-
By:
-
Antonio Regalado
About this listen
The world’s largest DNA sequencing company says it will form a new company to develop blood tests that cost $1,000 or less and can detect many types of cancer before symptoms arise. Illumina, based in San Diego, said its blood tests should reach the market by 2019, and would be offered through doctors’ offices or possibly a network of testing centers.
©2016 Massachusetts Institute of Technology (P)2016 Massachusetts Institute of Technology
No reviews yet